Submissions from 2025
Trends and outcomes of heart failure hospitalizations during COVID-19 pandemic, Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Atulya Khosla, Peter McGranaghan, Yanjia Zhang, Sandra Chaparro, and Javier Jimenez
Complexity and Experience Grading to Guide Patient Selection for Minimally-invasive Pancreatoduodenectomy: An ISGPS Consensus, Horacio Asbun
Impact of Social Determinants of Health on Cancer Treatment Referrals in Patients Living with HIV in the United States: A Narrative Review, Marco Ruiz Andia and Jannelle Vicens
Oral mucosal toxicities in oncology, Alessandro Villa
Quality of Cancer Recurrence Data in the National Cancer Database: A Reappraisal of Reporting Readiness, Vicki Hawhee and Karen Mason
Stereotactic Body Radiotherapy for liver metastases: Systematic review and meta-analysis with International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines, Rupesh Kotecha and Zhenwei Zhang
Weight loss, nutritional aspects and quality of life in head and neck cancer survivors, Alessandro Villa
Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma, Rupesh Kotecha
CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinoma, Guilherme Rabinowits
Evaluation of Human Papillomavirus Vaccination and Cancer Prevention Behaviors among LGBTQI + Individuals: A Cross-Sectional Study, Alessandro Villa
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions, Manmeet Ahluwalia
Leptomeningeal metastatic disease: new frontiers and future directions, Manmeet Ahluwalia
Mycobacterium immunogenum-Induced Thrombocytopenia, Sandra Sepulveda and Marco Ruiz-Andia
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era, Camila Masias
Oncological Outcomes of Patients With Oral Potentially Malignant Disorders, Alessandro Villa
Principles of Surgical Treatment of Soft Tissue Sarcomas, Juan Pretell
Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma, Yuliya Linhares
Ablative Five-Fraction CT Versus MR-Guided Stereotactic Body Radiation Therapy for Pancreatic Cancer: In Silico Evaluation of Interfraction Anatomic Changes as a Rationale for Online Adaptive Replanning, Adeel Kaiser, Nicole Luther, Kathryn Mittauer, Amna Gul, Robert Herrera, Mukesh Roy, Ashley Fellows, Amy Rzepczynski, Will Deere, Matthew Hall, Rupesh Kotecha, Nema Bassiri Gharb, Alonso Gutierrez, and Michael Chuong
Advances in stem cell-based therapeutic transfers for glioblastoma treatment, Mainak Bardhan, Vivek Podder, Manmeet Ahluwalia, Yazmin Odia, and Zhijian Chen